Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study

Código QR

Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study

Delphine Saragoussi,1 Maëlys Touya,2 Josep Maria Haro,3 Bengt Jönsson,4 Martin Knapp,5 Bastien Botrel,6 Ioana Florea,7 Henrik Loft,8 Benoît Rive9 1Real-World Evidence and Epidemiology, Lundbeck SAS, Issy-les-Moulineaux, France; 2Health Economics and Outcomes Research, Lu...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Saragoussi D, Touya M, Haro JM, Jönsson B, Knapp M, Botrel B, Florea I, Loft H, Rive B
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	major depressive disorder remission relapse patient-reported cognitive dysfunction Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/a118930eb9074b348715c38ad03d50bb
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Pioglitazone could induce remission in major depression: a meta-analysis
por: Colle R, et al.
Publicado: (2016)

Is histological remission of ulcerative colitis achievable?
por: Oleg V. Knyazev, et al.
Publicado: (2021)

Residual symptoms in patients with partial versus complete remission of a major depressive disorder episode: patterns of painful physical symptoms in depression
por: Harada E, et al.
Publicado: (2016)

ACHIEVEMENT OF REMISSION AS A MODERN PURPOSE OF ANTIDEPRESSANT THERAPY
por: O. V. Petrunko
Publicado: (2014)

Factors of long-term remission formation in patients with alcohol dependence
por: O. V. Petrunko, et al.
Publicado: (2017)

Evaluation of cognitive impairment in patients with major depressive disorder in remission
por: Mustafa Ali, et al.
Publicado: (2021)

Analysis of Endoscopic Evaluation Reliability for Ulcerative Colitis in Histological Remission
por: Mimari Kanazawa, et al.
Publicado: (2021)

Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder
por: Lam RW, et al.
Publicado: (2018)

Predictors of achieving remission in schizophrenia patients treated with paliperidone palmitate 3-month formulation
por: Nash AI, et al.
Publicado: (2019)

Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study
por: Saragoussi D, et al.
Publicado: (2018)

Perceived stress, quality of life, and coping skills among patients with schizophrenia in symptomatic remission
por: Sheikh Shoib, et al.
Publicado: (2021)

Duration Mismatch Negativity Predicts Remission in First-Episode Schizophrenia Patients
por: Suguru Nakajima, et al.
Publicado: (2021)

Functional impairment in patients with major depressive disorder: the 2-year PERFORM study
por: Hammer-Helmich L, et al.
Publicado: (2018)

Postoperative GH and Degree of Reduction in IGF-1 Predicts Postoperative Hormonal Remission in Acromegaly
por: Tyler Cardinal, et al.
Publicado: (2021)

Induction of remission in chronic urticaria by immunotherapy using immunoglobulin/histamine complex (Histobulin™): a case report
por: Hyuk Soon Kim, et al.
Publicado: (2021)

Altered cytokine profiles in relapsed paucibacillary leprosy: a case report
por: Tomoyuki Sameshima, et al.
Publicado: (2021)

Intravenous cyclophosphamide induces remission in children with difficult to treat steroid resistant nephrotic syndrome from minimal change disease
por: Maha Haddad, et al.
Publicado: (2021)

Associations between attention‐deficit hyperactivity disorder (ADHD) symptom remission and white matter microstructure: A longitudinal analysis
por: Anne E. M. Leenders, et al.
Publicado: (2021)

Rheumatoid Arthritis Saudi Database (RASD): Disease Characteristics and Remission Rates in a Tertiary Care Center
por: Almoallim H, et al.
Publicado: (2020)

Urinary excretion of IL-1β, IL-6 and IL-8 cytokines during relapse and remission of idiopathic nephrotic syndrome
por: Al-Eisa AA, et al.
Publicado: (2017)

ASSOCIATION OF HYPERDIPLOIDY WITH REMISSION STATUS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA AFTER INDUCTION THERAPY
por: Saqib Hussain Korejo, et al.
Publicado: (2019)

Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis
por: Liam J. O’Neil, et al.
Publicado: (2021)

Factors Associated with Non-Remission in Bipolar Disorder: The Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI)
por: Tsuboi T, et al.
Publicado: (2020)

Partial Clinical Remission Reduces Lipid-Based Cardiovascular Risk in Adult Patients With Type 1 Diabetes
por: Benjamin Udoka Nwosu, et al.
Publicado: (2021)

Predicting functional remission in patients with schizophrenia: a cross-sectional study of symptomatic remission, psychosocial remission, functioning, and clinical outcome
por: Valencia M, et al.
Publicado: (2015)

ANCA-Associated Vasculitis Clinical Presentation and Clinical Predictors of Relapse in Saudi Arabia
por: Alahmari H, et al.
Publicado: (2021)

Temperament, personality, and treatment outcome in major depression: a 6-month preliminary prospective study
por: Kudo Y, et al.
Publicado: (2016)

REFLECTING ON LIFE SCRIPT, RELATED UNCONSCIOUS BELIEFS, AND FUTURE PROJECTIONS AS A FACTOR OF REMISSION DURATION IN MALE PATIENTS WITH ALCOHOL DEPENDENCE
por: OLGA D. TUCHINA, et al.
Publicado: (2021)

Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study
por: Novick D, et al.
Publicado: (2015)

Time to relapse and remission of bipolar disorder: findings from a 1-year prospective study in Thailand
por: Leelahanaj T, et al.
Publicado: (2013)

Refractory relapsing polychondritis: challenges and solutions
por: Kemta Lekpa F, et al.
Publicado: (2018)

Lower serum brain-derived neurotrophic factor levels are associated with failure to achieve remission in patients with major depression after escitalopram treatment
por: Lee BH, et al.
Publicado: (2014)

Clinical Outcomes of Patients With Primary Membranous Nephropathy and Subnephrotic Proteinuria
por: Peng He, et al.
Publicado: (2021)

Treatment response in relation to subthreshold bipolarity in patients with major depressive disorder receiving antidepressant monotherapy: a post hoc data analysis (KOMDD study)
por: Park YM, et al.
Publicado: (2016)

Patient-reported depression severity and cognitive symptoms as determinants of functioning in patients with major depressive disorder: a secondary analysis of the 2-year prospective PERFORM study
por: Haro JM, et al.
Publicado: (2019)

Ocular Involvement in Relapsing Polychondritis
por: Ken Fukuda, et al.
Publicado: (2021)

Patient Expectations and Experiences of Antidepressant Therapy for Major Depressive Disorder: A Qualitative Study
por: Baune BT, et al.
Publicado: (2021)

Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review
por: Karson C, et al.
Publicado: (2016)

Associations among depression severity, painful physical symptoms, and social and occupational functioning impairment in patients with major depressive disorder: a 3-month, prospective, observational study
por: Harada E, et al.
Publicado: (2017)

Incidence of Ulcerative Colitis Relapse: A Prospective Cohort Study in Southern Iran
por: Seyed Vahid Hosseini, et al.
Publicado: (2016)